Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone for Asymptomatic CELs in RRMS
NCT04979650Phase 2Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- May 2021
- Primary completion
- Dec 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone in multiple sclerosis (MS), sponsored by Mazandaran University of Medical Sciences. Started May 2021; status: completed.
02
Drugs
methylprednisolone
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT04979650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04979650.